Article
Development of resistance to disoxaril in Coxsackie B1 virus-infected newborn mice.
Antiviral research - 1 Sept 2003
Nikolova Ivanka, Galabov Angel S
Abstract excerpt
Treatment with disoxaril (a WIN compound binding to the hydrophobic pocket within the enterovirus VP1 capsid protein) in newborn mice infected with Coxsackie B1 virus, for 10 days post virus inoculation at a daily subcutaneous dose of 25mg/kg decreased the virus titer in the mouse brain till day...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
